the progression of retinopathy was reevaluated at two years in 64 of the 68 patients with mild to moderate diabetic retinopathy , originally randomly assigned for an eight-month period either to intensified diabetic control with continuous subcutaneous insulin infusion ( csii ) or to unchanged conventional injection treatment .
C0035309
retinopathy
C0011884
diabetic retinopathy